International Journal of Radiation Oncology * Biology * Physics
Volume 47, Issue 5 , Pages 1177-1183 , 15 July 2000

Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined

Presented at the 41st Annual Meeting of the ASTRO, November 1, 1999.

  • Raj V Iyer, M.D.

      Affiliations

    • Departments of Department ofRadiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • Alexandra Hanlon, Ph.D.

      Affiliations

    • Departments of Department ofRadiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • Division of Population Science and Department of Biostatistics, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • Barbara Fowble, M.D.

      Affiliations

    • Departments of Department ofRadiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • Corresponding Author InformationReprint requests to: Dr. Barbara Fowble, Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111
    • ,
  • Gary Freedman, M.D.

      Affiliations

    • Departments of Department ofRadiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • Nicos Nicolaou, M.D.

      Affiliations

    • Departments of Department ofRadiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • Penny Anderson, M.D.

      Affiliations

    • Departments of Department ofRadiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • John Hoffman, M.D.

      Affiliations

    • Department ofSurgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • Elin Sigurdson, M.D., Ph.D.

      Affiliations

    • Department ofSurgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • Marcia Boraas, M.D.

      Affiliations

    • Department ofSurgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    • ,
  • Michael Torosian, M.D.

      Affiliations

    • Department ofSurgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

,Accepted 1 December 1999.

References 

  1. Axelsson CK, Mouridsen HT, Zedeler K, et al.  Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer. 1992;28A:1415–1418
  2. Ciatto S, Pacini P, DelTurco MR, et al.  Patterns of axillary metastases in breast cancer. Radiother Oncol. 1986;5:91–94
  3. Fisher B, Wolmark N, Bauer M, et al.  The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981;152:765–772
  4. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer. 1992;69:2496–2501
  5. Rose CM, Botnick LE, Weinstein M, et al.  Axillary sampling in the definitive tratment of breast cancer by radiation therapy and lumpectomy. Int J Radiat Oncol Biol Phys. 1983;9:339–344
  6. Fisher B, Bauer M, Wickerham L, et al.  Relation of number of positive axillary nodes to prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52:1551
  7. Recht A, Gray R, Davidson NE, et al.  Local-regional failure ten years following mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation (Experience of the Easter Cooperative Oncology Group). J Clin Oncol. 1999;17:1689–1700
  8. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy (Analysis of 716 consecutive patients). Cancer. 1978;41:1170–1178
  9. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–187
  10. Nemoto T, Vana J, Bedwani RN, et al.  Management and survival of female breast cancer (Results of a national survey by the American College of Surgeons). Cancer. 1980;45:2917–2924
  11. Fisher B, Slack N, Katrych DL, et al.  Ten year follow-up of patients in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet. 1975;140:528–534
  12. Fowble B. Postmastectomy radiation (Then and now). Oncology. 1997;11:213–239
  13. Vicini FA, Horwitz EM, Lacerna MD, et al.  The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1997;39:1069–1076
  14. Danforth DM, Findlay PA, McDonald HD, et al.  Complete axillary lymph node dissection for stage I–II carcinoma of the breast. J Clin Oncol. 1986;4:655
  15. Veronesi U, Luini A, Galimberti S, et al.  Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol. 1990;16:127–133
  16. Veronesi U, Rilke F, Luini A. Distribution of axillary node metastases by level. Cancer. 1987;59:682
  17. Boova RS, Bonani R, Rosato FE. Patterns of axillary and nodal involvement in breast cancer (predictability of level one dissection). Ann Surg. 1982;196:642
  18. Rosen PP, Lesser ML, Kinne DW, et al.  Discontinuous of “skip” metastases in breast carcinoma. Ann Surg. 1983;187:276
  19. Krag D, Weaver D, Ashikaga T, et al.  The sentinel node in breast cancer. N Engl J Med. 1998;339:941–946
  20. Elston CW, Gresham GA, Rao GS, et al.  The Cancer Research Campaign (Kings’s/Cambridge) trial for early breast cancer (clinico-pathologic aspects). Br J Cancer. 1982;45:655–669
  21. Ragaz J, Jackson SM, Nhu L, et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  22. Willemse PHB, Otter R, Schaapveld M, et al.  Quality analysis of axillary lymph node dissection in breast cancer patients in the northern part of the Netherlands. (Abstract) Proc Am Soc Clin Oncol. 1999;18:76a
  23. Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet. 1970;131:79–88
  24. Wilking N, Rutqvist LE, Carstensen J, et al.  Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol. 1992;31:29–35
  25. Korzeniowski S, Dyba T, Skolyszewski J. Classical prognostic factors for survival and loco-regional control in breast cancer patients treated with radical mastectomy alone. Acta Oncol. 1994;33:759–765
  26. Kahlert SD, Konecny G, Nestle-Kraemling C, et al.  Extent of axillary lymph node dissection—A source of misinterpretation but not a prognostic factor. (Abstract) Proc Am Soc Clin Oncol. 1999;18:76a
  27. Overgaard M, Hansen PS, Overgaard J, et al.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–955
  28. Recht A. Local-regional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy. Semin Radiat Oncol. 1999;9:223–229
  29. Overgaard M, Jensen M-B, Overgaard J, et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen (Danish Breast Cancer Cooperative Group DBCG 82c randomized trial). Lancet. 1999;353:1641–1648
  30. Velez-Garcia E, Carpenter JT, Moore M, et al.  Post surgical adjuvant. chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes (A Southeastern Cancer Study Group (SEG) Trial). Eur J Cancer Clin Oncol. 1992;28A:1833–1837
  31. Fowble B. Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy (An unresolved issue). Semin Radiat Oncol. 1999;9:230–240
  32. Recht A, Galper SR, Silver B, et al.  Factors associated with regional node failure in patients with early stage breast cancer with 0 to 3 positive axillary nodes following tangential breast irradiation alone. (Abstract) Int J Radiat Oncol Biol Phys. 1998;42:181
  33. Reynolds C, Mick R, Donohue JH, et al.  Sentinel lymph node biopsy with metastases (Can axillary dissection be avoided in some patients with breast cancer?). J Clin Oncol. 1999;17:1720–1726
  34. Chu KU, Turner RR, Hansen NM, et al.  Do all patients with sentinel node metastases from breast carcinoma need complete axillary dissection?. Ann Surg. 1999;229:536–541
  35. Veronesi U, Paganelli G, Viale G, et al.  Sentinel lymph node biopsy and axillary dissection in breast cancer (Results in a large series). J Natl Cancer Inst. 1999;91:368–373

PII: S0360-3016(00)00574-5

doi: 10.1016/S0360-3016(00)00574-5

International Journal of Radiation Oncology * Biology * Physics
Volume 47, Issue 5 , Pages 1177-1183 , 15 July 2000

Article Tools